Article

Board members include industry leaders, investors

Alimera Sciences Inc. has added two notable names in the ophthalmology industry to its board of directors.

Alimera Sciences Inc. has added two notable names in the ophthalmology industry to its board of directors.

Steve Martin, JD, a former president of CIBA Vision Corp. USA and founder of its optics and ophthalmics business, and Calvin W. Roberts, MD, clinical professor of ophthalmology at Weill Medical College at Cornell University, joined the board in July.

Martin is chief executive officer and partner at Hi Tech Partners in Atlanta, where he advises early-stage technology firms.

They join representatives from each of the four venture capital firms that invested in Alimera Sciences. Intersouth Partners led financing with more than $6 million, an amount matched by BA Venture Partners, Domain Associates, and Polaris Venture Partners.OT

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.